» Articles » PMID: 37524903

Long Non-coding RNA SOX2-OT Enhances Cancer Biological Traits Via Sponging to Tumor Suppressor MiR-122-3p and MiR-194-5p in Non-small Cell Lung Carcinoma

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jul 31
PMID 37524903
Authors
Affiliations
Soon will be listed here.
Abstract

The oncogenic role of long non-coding RNA SOX2 overlapping transcript (SOX2-OT) has been demonstrated as a miRNA decay system that sponges tumor suppressor miRNA, including miR-122-3p in glioblastoma and miR-194-5p in glioblastoma, gastric, and colorectal cancers. However, the molecular function of SOX2-OT remains unknown in most cancers, including lung cancer. In the current study, we aimed to evaluate the downstream regulatory function of SOX2-OT in A549 and Calu-3 lung cancer cell lines. We knocked down SOX2-OT expression using an RNA interference system, which significantly decreased expression in A549 and Calu-3 cells. The expression of down-regulating miRNAs (miR-122-3p and miR-194-5p) was evaluated, revealing increased expression of miR-122-3p and miR-194-5p. Additionally, the expression of miRNAs downstream mRNA, including FOXO1 (Forkhead Box O1) and FOXA1 (Forkhead Box O1), changed. Recently, critical roles of FOXO1 and FOXA1 proteins in pathways involved in proliferation, metastasis and apoptosis have been demonstrated. Downstream changes in cellular traits were assessed using MTT, flow cytometry, metastasis and apoptosis assays. These assessments confirmed that the biological behaviors of lung cancer cells were influenced after SOX2-OT knockdown. In summary, the present study highlights the oncogenic role of SOX2-OT through the regulation of miR-122-3p/FOXO1 and miR-194-5p/FOXA1 pathways.

Citing Articles

The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.

Yang J, Tan F, Chen Y, Li X, Yuan C J Physiol Biochem. 2024; .

PMID: 39702742 DOI: 10.1007/s13105-024-01059-2.


Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer.

Karimzadeh M, Momen-Roknabadi A, Cavazos T, Fang Y, Chen N, Multhaup M Nat Commun. 2024; 15(1):10090.

PMID: 39572521 PMC: 11582319. DOI: 10.1038/s41467-024-53851-9.


The Growth of A549 Cell Line is Inhibited by Pemetrexed Through Up-regulation of hsa-MiR-320a Expression.

Alvanegh A, Esmaeili Gouvarchin Ghaleh H, Mohammad Ganji S Adv Biomed Res. 2024; 13:50.

PMID: 39411702 PMC: 11478724. DOI: 10.4103/abr.abr_483_23.


Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.

Lv X, Yang L, Xie Y, Momeni M Front Cell Dev Biol. 2024; 12:1397788.

PMID: 38859962 PMC: 11163066. DOI: 10.3389/fcell.2024.1397788.


Diagnostic Accuracy of Exosomal Long Noncoding RNAs in Diagnosis of NSCLC: A Meta-Analysis.

Song X, Duan L, Dong Y Mol Diagn Ther. 2024; 28(4):455-468.

PMID: 38837024 DOI: 10.1007/s40291-024-00715-z.

References
1.
Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

2.
Wang H, Meyer C, Fei T, Wang G, Zhang F, Liu X . A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer. BMC Genomics. 2013; 14:680. PMC: 3852829. DOI: 10.1186/1471-2164-14-680. View

3.
Teng Y, Kang H, Chu Y . Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma. Genet Test Mol Biomarkers. 2019; 23(4):235-240. DOI: 10.1089/gtmb.2018.0103. View

4.
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J . Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. Mol Cancer. 2017; 16(1):171. PMC: 5683208. DOI: 10.1186/s12943-017-0737-1. View

5.
Xie W, Yuan S, Sun Z, Li Y . Long noncoding and circular RNAs in lung cancer: advances and perspectives. Epigenomics. 2016; 8(9):1275-87. DOI: 10.2217/epi-2016-0036. View